Icure Pharmaceutical Incorporation (175250) — Free Cash Flow Generation Index

Latest as of June 2020: 39.07x

Icure Pharmaceutical Incorporation (175250) has a Free Cash Flow Generation Index of 39.07x as of June 2020. Free cash flow of ₩7.64 Billion represents 39% of operating cash flow (₩195.44 Million). Explore 175250 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

39.07x

Free Cash Flow / Operating CF

Free Cash Flow

₩7.64 Billion

KRW

Operating Cash Flow

₩195.44 Million

KRW

Capital Expenditures

₩7.44 Billion

KRW

Icure Pharmaceutical Incorporation Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for Icure Pharmaceutical Incorporation across 1 annual periods. For the full cash flow conversion analysis, see Icure Pharmaceutical Incorporation operating cash flow efficiency.

Annual Free Cash Flow Generation for Icure Pharmaceutical Incorporation (2017–2017)

Year-by-year Free Cash Flow Generation Index for Icure Pharmaceutical Incorporation. Check total reinvestment intensity of Icure Pharmaceutical Incorporation to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2017	10.02x	₩11.22 Billion	₩1.12 Billion	₩10.10 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).